peptides vs tirzepatide Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison Semaglutide vs Tirzepatide: Research Comparison

Marketed under the brand names Mounjaro for type 2 diabetes and Zepbound for chronic weight management, tirzepatide was approved by the FDA in May 2022 and November 2023, respectively

Balqees Ara at the PNS 2024 Annual Meeting and involved collaboration with the Charleston Area Medical Center Institute for Academic Medicine, West Virginia University, and other institutions

(Figure 1) Figure 1: Mean insulin concentration at 0-120 minutes during hyperglycemic clamp at baseline and Week 28 Insulin Sensitivity Tirzepatide increases insulin sensitivity, as demonstrated in a hyperinsulinemic euglycemic clamp study after 28 weeks of treatment

Key Takeaway: Supporting your body with adequate sleep and targeted nutrition can significantly reduce the intensity of common side effects